299 assets in Alzheimer Disease

Therapeutic assets addressing Alzheimer Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Foralumab Tzls-401 Alzheimer Disease	Brigham and Women's Hospital	P2	CCC (53)
Histidine Alzheimer Disease	Wake Forest University Health Sciences	P4	CCC (53)
Human Mesenchymal Stem Cells Alzheimer Disease	Bernard (Barry) Baumel	P2	CCC (53)
kds2010 Alzheimer Disease	NeuroBiogen Co., Ltd	P2	CCC (53)
Leronlimab Alzheimer Disease	Weill Medical College of Cornell University	P2	CCC (53)
Mivelsiran Alzheimer Disease	Alnylam Pharmaceuticals	P2	CCC (53)
Ono-2020 Alzheimer Disease	Ono Pharmaceutical Co., Ltd.	P2	CCC (53)
Ttyp01 Tables Alzheimer Disease	Shanghai Auzone Biological Technology Co., Ltd.	P2	CCC (53)
Varoglutamstat Alzheimer Disease	Vivoryon Therapeutics N.V.	P2	CCC (53)
Zagociguat Alzheimer Disease	Tisento Therapeutics	P2	CCC (53)
[18F]Flornaptitril Alzheimer Disease	CereMark Pharma, LLC	P3	CCC (52)
bey2153 Alzheimer Disease	BeyondBio Inc.	P2	CCC (52)
Florquinitau Alzheimer Disease	Sinotau Pharmaceutical Group	P3	CCC (52)
Hmscs Alzheimer Disease	Bernard (Barry) Baumel	P2	CCC (52)
Igc Ad1 Alzheimer Disease	IGC Pharma, LLC	P2	CCC (52)
Immunoglobulin G1, Anti-(Human 1-40-.Beta.-Amyloid/Human 1-42-.Beta.-Amyloid) (Human Monoclonal .Gamma.1-Chain), Disulfide With Human Monoclonal .Kappa.-Chain, Dimer Alzheimer Disease	Hoffmann-La Roche	P3	CCC (52)
Karx-Ec Alzheimer Disease	Bristol-Myers Squibb	P3	CCC (52)
Karxt Alzheimer Disease	Bristol-Myers Squibb	P3	CCC (52)
Maltodextrin Alzheimer Disease	ScandiBio Therapeutics AB	P3	CCC (52)
mk-2214 Alzheimer Disease	Merck Sharp & Dohme LLC	P2	CCC (52)
Nilotinib Be Alzheimer Disease	KeifeRx, LLC	P3	CCC (52)
Ntrx-07 Alzheimer Disease	NeuroTherapia, Inc.	P2	CCC (52)
Pri-002 Alzheimer Disease	PRInnovation GmbH	P2	CCC (52)
Rb-Adsc Alzheimer Disease	Regeneration Biomedical, Inc.	P2	CCC (52)
Sabirnetug Alzheimer Disease	Acumen Pharmaceuticals	P2	CCC (52)
Tacrolimus Alzheimer Disease	Second Affiliated Hospital of Nanchang University	P2	CCC (52)
Xanomeline Enteric Alzheimer Disease	Bristol-Myers Squibb	P3	CCC (52)
((3AR,6AS)-5-(4,6-DIMETHYLPYRIMIDIN- 2-YL)HEXAHYDROPYRROLO(3,4-C)PYRROL-2(1H)-YL)(2-FLUORO- 6-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE OREXIN RECEPTOR ANTAGONIST Alzheimer Disease	Janssen Research & Development, LLC	P2	CCC (51)
asn51 Alzheimer Disease	Asceneuron S.A.	P2	CCC (51)
Astragalus Membranaceus Root Alzheimer Disease	Fujian Medical University Union Hospital	P2	CCC (51)
Benfotiamine Alzheimer Disease	Alzheimer's Disease Cooperative Study (ADCS)	P2	CCC (51)
Empagliflozin Alzheimer Disease	Wake Forest University Health Sciences	P2	CCC (51)
Formoterol Alzheimer Disease	Palo Alto Veterans Institute for Research	P2	CCC (51)
gsk4527226 Alzheimer Disease	GlaxoSmithKline	P2	CCC (51)
Hydroxypropyl-Beta-Cyclodextrin Alzheimer Disease	Cyclo Therapeutics, Inc.	P2	CCC (51)
ly3372689 Alzheimer Disease	Eli Lilly and Company	P2	CCC (51)
Mevidalen Alzheimer Disease	Eli Lilly and Company	P2	CCC (51)
mk-1167 Alzheimer Disease	Merck Sharp & Dohme LLC	P2	CCC (51)
rem0046127 Alzheimer Disease	reMYND	P2	CCC (51)
ro7269162 Alzheimer Disease	Hoffmann-La Roche	P2	CCC (51)
Sls-005 Alzheimer Disease	Seelos Therapeutics, Inc.	P2	CCC (51)
tw001 Alzheimer Disease	Treeway B.V.	P2	CCC (51)
vhb937 Alzheimer Disease	Novartis Pharmaceuticals	P2	CCC (51)
Dexmedetomidine Alzheimer Disease	Applied Cognition	P1/2	CCC (49)
lx1001 Alzheimer Disease	Lexeo Therapeutics	P1/2	CCC (49)
5-Hexenamide, 6-(3,4-dimethoxyphenyl)-3-[(2E)-3-(3,4-dimethoxyphenyl)-1-oxo-2-propen-1-yl]-N,N-diethyl-3-methyl-4-oxo-, (5E)- Alzheimer Disease	Merry Life Biomedical Co., Ltd.	P2	CCC (48)
Acellular Pertussis Vaccine Alzheimer Disease	Mindful Diagnostics and Therapeutics, LLC	P1/2	CCC (48)
Aci-24.060 Alzheimer Disease	AC Immune SA	P1/2	CCC (48)
Amdx-2011P Alzheimer Disease	Amydis Inc.	P2	CCC (48)
Astragalus Alzheimer Disease	Fujian Medical University Union Hospital	P2	CCC (48)

Showing 101 to 150 of 299 assets

PreviousPage 3 of 6Next